A food-derived molecule that helps cells recycle worn parts. The case rests on animal lifespan work and population studies tying spermidine-rich eating to longer survival and lower blood pressure; a large Japanese population found nothing and hinted at more cancer deaths in women. Swallowed spermidine does not raise blood levels, so tissue delivery is unresolved. (Full Review)
| Marker | Target | Why |
|---|---|---|
| High-sensitivity C-reactive protein | Below 0.5 mg/L | Tracks the inflammation signal seen in exploratory trial analyses |
| Ambulatory blood pressure, 24 hours | Below 120/75 mmHg daytime mean | The one cardiovascular endpoint with both an animal and an observational signal |
| Estimated glomerular filtration rate | At or above 90 mL/min/1.73 m² | Confirms the renal clearance route for acetylated polyamines is intact |
| Alanine aminotransferase | 10–26 U/L in men, 8–22 U/L in women | Standard safety monitoring, matching the trial panels |
| Fasting insulin | 2–5 µIU/mL | Captures the metabolic domain where preclinical claims are strongest |
| Triglyceride to HDL cholesterol ratio | Below 1.5 (mg/dL units) | Practical readout of the lipid handling claimed from rodent work |
| Complete blood count | Within laboratory reference limits, stable against own baseline | Detects any marrow or immune effect of a compound that drives cell proliferation |
| Homocysteine | 5–7 µmol/L | Polyamine synthesis consumes the body's main methyl donor, so heavy flux could show here |
| Plasma spermidine | No established target, and it does not rise with supplementation; track change from personal baseline instead | Documents the central pharmacokinetic problem rather than a treatment goal |
| Tissue transglutaminase IgA | Negative | Screens for celiac disease before committing to a wheat-germ product |
Cadence: Baseline before starting, then the safety panel at 3 months, at 12 months, then every 12 months while use continues. Blood pressure: home checks twice daily for the first two weeks in anyone on antihypertensives, then monthly.